» Articles » PMID: 25161247

Drug Susceptibility Prediction Against a Panel of Drugs Using Kernelized Bayesian Multitask Learning

Overview
Journal Bioinformatics
Specialty Biology
Date 2014 Aug 28
PMID 25161247
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Motivation: Human immunodeficiency virus (HIV) and cancer require personalized therapies owing to their inherent heterogeneous nature. For both diseases, large-scale pharmacogenomic screens of molecularly characterized samples have been generated with the hope of identifying genetic predictors of drug susceptibility. Thus, computational algorithms capable of inferring robust predictors of drug responses from genomic information are of great practical importance. Most of the existing computational studies that consider drug susceptibility prediction against a panel of drugs formulate a separate learning problem for each drug, which cannot make use of commonalities between subsets of drugs.

Results: In this study, we propose to solve the problem of drug susceptibility prediction against a panel of drugs in a multitask learning framework by formulating a novel Bayesian algorithm that combines kernel-based non-linear dimensionality reduction and binary classification (or regression). The main novelty of our method is the joint Bayesian formulation of projecting data points into a shared subspace and learning predictive models for all drugs in this subspace, which helps us to eliminate off-target effects and drug-specific experimental noise. Another novelty of our method is the ability of handling missing phenotype values owing to experimental conditions and quality control reasons. We demonstrate the performance of our algorithm via cross-validation experiments on two benchmark drug susceptibility datasets of HIV and cancer. Our method obtains statistically significantly better predictive performance on most of the drugs compared with baseline single-task algorithms that learn drug-specific models. These results show that predicting drug susceptibility against a panel of drugs simultaneously within a multitask learning framework improves overall predictive performance over single-task learning approaches.

Availability And Implementation: Our Matlab implementations for binary classification and regression are available at https://github.com/mehmetgonen/kbmtl.

Supplementary Information: Supplementary data are available at Bioinformatics online.

Citing Articles

Model ensembling as a tool to form interpretable multi-omic predictors of cancer pharmacosensitivity.

De Landtsheer S, Badkas A, Kulms D, Sauter T Brief Bioinform. 2024; 25(6).

PMID: 39494610 PMC: 11532660. DOI: 10.1093/bib/bbae567.


Trust me if you can: a survey on reliability and interpretability of machine learning approaches for drug sensitivity prediction in cancer.

Lenhof K, Eckhart L, Rolli L, Lenhof H Brief Bioinform. 2024; 25(5).

PMID: 39101498 PMC: 11299037. DOI: 10.1093/bib/bbae379.


Integrated single-dose kinome profiling data is predictive of cancer cell line sensitivity to kinase inhibitors.

Joisa C, Chen K, Berginski M, Golitz B, Jenner M, Herrera Loeza G PeerJ. 2023; 11:e16342.

PMID: 38025707 PMC: 10657565. DOI: 10.7717/peerj.16342.


Multimodal learning in clinical proteomics: enhancing antimicrobial resistance prediction models with chemical information.

Visona G, Duroux D, Miranda L, Sukei E, Li Y, Borgwardt K Bioinformatics. 2023; 39(12).

PMID: 38001023 PMC: 10724849. DOI: 10.1093/bioinformatics/btad717.


Identifying Tissue- and Cohort-Specific RNA Regulatory Modules in Cancer Cells Using Multitask Learning.

Mokhtaridoost M, Maass P, Gonen M Cancers (Basel). 2022; 14(19).

PMID: 36230862 PMC: 9563725. DOI: 10.3390/cancers14194939.


References
1.
Menden M, Iorio F, Garnett M, McDermott U, Benes C, Ballester P . Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties. PLoS One. 2013; 8(4):e61318. PMC: 3640019. DOI: 10.1371/journal.pone.0061318. View

2.
Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin A, Kim S . The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012; 483(7391):603-7. PMC: 3320027. DOI: 10.1038/nature11003. View

3.
Jang I, Chaibub Neto E, Guinney J, Friend S, Margolin A . Systematic assessment of analytical methods for drug sensitivity prediction from cancer cell line data. Pac Symp Biocomput. 2013; :63-74. PMC: 3995541. View

4.
Papillon-Cavanagh S, De Jay N, Hachem N, Olsen C, Bontempi G, Aerts H . Comparison and validation of genomic predictors for anticancer drug sensitivity. J Am Med Inform Assoc. 2013; 20(4):597-602. PMC: 3721163. DOI: 10.1136/amiajnl-2012-001442. View

5.
Heider D, Senge R, Cheng W, Hullermeier E . Multilabel classification for exploiting cross-resistance information in HIV-1 drug resistance prediction. Bioinformatics. 2013; 29(16):1946-52. DOI: 10.1093/bioinformatics/btt331. View